Correlation between dopaminergic and metabolic asymmetry in Lewy body disease - A dual-imaging study

Parkinsonism Relat Disord. 2024 Oct:127:107117. doi: 10.1016/j.parkreldis.2024.107117. Epub 2024 Aug 30.

Abstract

Introduction: The a-Synuclein Origin and Connectome (SOC) model of Lewy body diseases postulates that a-syuclein will be asymmetrically distributed in some patients with Lewy body diseases, potentially leading to asymmetric neuronal dysfunction and symptoms.

Methods: We included two patient groups: 19 non-demented Parkinson's disease (nPD) patients with [18F]FDG PET and motor symptoms assessed by UPDRS-III, and 65 Lewy body dementia (LBD) patients with [18F]FDG PET and dopamine radioisotope imaging. Asymmetry indices were calculated for [18F]FDG PET by including the cortex for each hemisphere, for dopamine radioisotope imaging by including the putamen and caudate separately, and for motor symptoms by using the difference between right-left UPDRS-III score. Correlations between these asymmetry indices were explored to test the predictions of the SOC model. To identify cases with a more typical LBD imaging profile, we calculated a Cingulate Island Sign (CIS) index on the [18F]FDG PET image.

Results: We found a significant correlation between cortical interhemispheric [18F]FDG asymmetry and motor-symptom asymmetry in nPD patients (r = 0.62, P = 0.004). In patients with LBD, we found a significant correlation between cortical interhemispheric [18F]FDG asymmetry and dopamine transporter asymmetry in the caudate (r = 0.37, P = 0.0019), but not in the putamen (r = 0.15, P = 0.22). We observed that the correlation in the caudate was stronger in LBD subjects with the highest CIS index, i.e., with more typical LBD imaging profiles.

Conclusion: Our study partly supports the SOC model, but further investigations are needed - ideally of de novo, non-demented PD patients.

Keywords: Asymmetry; Imaging; Lewy body dementia; Lewy body disease; Parkinson's disease.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Connectome
  • Dopamine / metabolism
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Lewy Body Disease* / diagnostic imaging
  • Lewy Body Disease* / metabolism
  • Male
  • Middle Aged
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / metabolism
  • Positron-Emission Tomography*
  • Putamen / diagnostic imaging
  • Putamen / metabolism

Substances

  • Fluorodeoxyglucose F18
  • Dopamine